Kaposiform Hemangioendothelioma
Symptoms, Doctors, Treatments, Advances & More

Kaposiform Hemangioendothelioma Overview

Save information for later
Sign Up

Learn About Kaposiform Hemangioendothelioma

What is the definition of Kaposiform Hemangioendothelioma?
A rare low-grade malignant cutaneous or visceral vascular tumour that may be associated with severe thrombopaenia with consumption coagulopathy (Kasabach-Merritt syndrome) in pediatric patients.
What are the alternative names for Kaposiform Hemangioendothelioma?
  • Kaposiform Hemangioendothelioma
  • Congenital cutaneous multifocal kaposiform hemangioendothelioma
  • KH
  • KHE
  • Kaposiform hemangio-endothelioma
Who are the top Kaposiform Hemangioendothelioma Local Doctors?
Advanced in Kaposiform Hemangioendothelioma
Advanced in Kaposiform Hemangioendothelioma
Referral may be required
Before you request

Indian River Health Services Inc

3555 10th Ct, Suite 200a, 
Vero Beach, FL 
772-563-4673
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathan Braue is a Dermatologist practicing medicine in Vero Beach, Florida. Dr. Braue is rated as an Advanced provider by MediFind in the treatment of Kaposiform Hemangioendothelioma. He is also highly rated in 56 other conditions, according to our data. His clinical expertise encompasses Sunburn, Actinic Keratosis, Warts, and Seborrheic Keratosis. Dr. Braue is board certified in American Board Of Dermatology, 2019. Dr. Braue is currently accepting new patients.

Advanced in Kaposiform Hemangioendothelioma
Advanced in Kaposiform Hemangioendothelioma
Referral may be required
Before you request

Avera Medical Group Dermatology — Mitchell

1900 Grassland Dr 3rd, Floor, 
Mitchell, SD 
605-995-7020
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mandi Greenway is a Dermatologist practicing medicine in Mitchell, South Dakota. Dr. Greenway is rated as an Advanced provider by MediFind in the treatment of Kaposiform Hemangioendothelioma. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Warts, Seborrheic Keratosis, and Melanoma. Dr. Greenway is board certified in American Board Of Dermatology. Dr. Greenway is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Kaposiform Hemangioendothelioma
Advanced in Kaposiform Hemangioendothelioma
Referral required
Before you request

Avera Dermatology — Pierre

801 E Sioux Ave, Floor 2, 
Pierre, SD 
605-945-5217
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Katie Bonnichsen is a Dermatologist practicing medicine in Pierre, South Dakota. Dr. Bonnichsen is rated as an Advanced provider by MediFind in the treatment of Kaposiform Hemangioendothelioma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Seborrheic Keratosis, Warts, and Kaposiform Hemangioendothelioma. Dr. Bonnichsen is board certified in Eligible - American Board Of Dermatology. Dr. Bonnichsen is currently accepting new patients.

View All Doctors
What are the latest Kaposiform Hemangioendothelioma Clinical Trials?
Low-dose Versus High-dose Sirolimus Combined With Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: a Randomized Noninferiority Trial
Low-dose Versus High-dose Sirolimus Combined With Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: a Randomized Noninferiority Trial
Enrollment Status: Recruiting
Publish Date: June 18, 2026
Intervention Type: Drug
Study Phase: Phase 2/Phase 3

Summary: This randomized clinical trial evaluates if low-dose sirolimus (target trough 4-8 ng/mL) combined with prednisolone is noninferior in efficacy but superior in safety compared to standard high-dose sirolimus (target trough 10-15 ng/mL) combined with prednisolone in pediatric patients with kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon (KHE with KMP), with participants randomized 1:...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Effect of Sirolimus on Time-sequentially Scheduled Immunizations During the Treatment of Kaposiform Hemangioendothelioma: a Case-control Study
The Effect of Sirolimus on Time-sequentially Scheduled Immunizations During the Treatment of Kaposiform Hemangioendothelioma: a Case-control Study
Enrollment Status: Recruiting
Publish Date: June 27, 2025
Intervention Type: Other

Summary: To research and explore the antibody protection and immune memory after vaccination in children with KHE during sirolimus administration. To explore the feasibility (safety and efficacy) of vaccination in a timely manner during the administration of sirolimus in children with KHE. To search for back-up plans for vaccination regimens for KHE patients taking sirolimus in children who do not respond ...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center